In 2025, I-Mab's return on capital employed (ROCE) was -0.25, a 25.83% increase from the -0.2 ROCE in the previous year.

I-Mab Aktienanalyse

What does I-Mab do?

I-Mab is a Chinese biopharmaceutical company specializing in the development of innovative therapies for the treatment of cancer and autoimmune diseases. It was founded in 2016 by Dr. Jingwu Zang and is based in Shanghai, China. I-Mab's business model focuses on the development of antibody therapies tailored to the needs of cancer and autoimmune patients. They utilize the latest research and development to create therapies that address the unmet market demand. They work on cancer immunotherapy, including CAR-T cell therapy, and also on immunotherapy for autoimmune diseases, including rare ones. Their goal is to improve the lives of patients with cancer and autoimmune diseases through innovative biotechnology and research. They have promising products in development and clinical trials, such as AMG 228 and TJM2. They aim to make a significant contribution to healthcare with their dedicated team of researchers and scientists. I-Mab ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling I-Mab's Return on Capital Employed (ROCE)

I-Mab's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing I-Mab's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

I-Mab's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in I-Mab’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about I-Mab stock

What is the ROCE (Return on Capital Employed) of I-Mab this year?

The ROCE of I-Mab is -0.25 undefined this year.

How has the ROCE (Return on Capital Employed) of I-Mab developed compared to the previous year?

The ROCE of I-Mab has increased by 25.83% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of I-Mab?

A high Return on Capital Employed (ROCE) indicates that I-Mab has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of I-Mab?

A low ROCE (Return on Capital Employed) can indicate that I-Mab has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from I-Mab impact the company?

An increase in the ROCE of I-Mab can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of I-Mab affect the company?

A decrease in ROCE of I-Mab can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of I-Mab?

Some factors that can affect I-Mab's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of I-Mab so important for investors?

The ROCE of I-Mab is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can I-Mab take to improve the ROCE?

To improve the ROCE, I-Mab can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does I-Mab pay?

Over the past 12 months, I-Mab paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, I-Mab is expected to pay a dividend of 0 USD.

What is the dividend yield of I-Mab?

The current dividend yield of I-Mab is .

When does I-Mab pay dividends?

I-Mab pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of I-Mab?

I-Mab paid dividends every year for the past 0 years.

What is the dividend of I-Mab?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is I-Mab located?

I-Mab is assigned to the 'Health' sector.

Wann musste ich die Aktien von I-Mab kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of I-Mab from 10/7/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/7/2025.

When did I-Mab pay the last dividend?

The last dividend was paid out on 10/7/2025.

What was the dividend of I-Mab in the year 2024?

In the year 2024, I-Mab distributed 0 USD as dividends.

In which currency does I-Mab pay out the dividend?

The dividends of I-Mab are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von I-Mab

Our stock analysis for I-Mab Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of I-Mab Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.